Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
4,503,909
-
Total 13F shares
-
1,985,734
-
Share change
-
+1,738,866
-
Total reported value
-
$4,329,059
-
Price per share
-
$2.18
-
Number of holders
-
11
-
Value change
-
+$3,787,212
-
Number of buys
-
5
-
Number of sells
-
2
Institutional Holders of Cellectar Biosciences, Inc. - Common Shares (CLRB) as of Q2 2019
As of 30 Jun 2019,
Cellectar Biosciences, Inc. - Common Shares (CLRB) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,985,734 shares.
The largest 10 holders included
BOXER CAPITAL, LLC, TANG CAPITAL MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, CVI Holdings, LLC, SPHERA FUNDS MANAGEMENT LTD., MORGAN STANLEY, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, LADENBURG THALMANN FINANCIAL SERVICES INC., and US BANCORP \DE\.
This page lists
11
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.